Chromosome aberrations in solid tumors

Chromosome aberrations in human solid tumors are hallmarks of gene deregulation and genome instability. This review summarizes current knowledge regarding aberrations, discusses their functional importance, suggests mechanisms by which aberrations may form during cancer progression and provides examples of clinical advances that have come from studies of chromosome aberrations.

[1]  R T Schimke,et al.  Gene amplification and drug resistance in cultured murine cells. , 1978, Science.

[2]  G R Stark,et al.  Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells. , 1979, The Journal of biological chemistry.

[3]  J. Stephenson,et al.  A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia , 1982, Nature.

[4]  H. Varmus,et al.  Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. P. Dryja,et al.  Expression of recessive alleles by chromosomal mechanisms in retinoblastoma , 1983, Nature.

[6]  H. Sather,et al.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.

[7]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[8]  B. Dutrillaux,et al.  Cytogenetics of colorectal adenocarcinomas. , 1990, Cancer genetics and cytogenetics.

[9]  R. Myers,et al.  Structure and variability of human chromosome ends , 1990, Molecular and cellular biology.

[10]  B. Vogelstein,et al.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. , 1990, Cancer research.

[11]  Robin C. Allshire,et al.  Telomere reduction in human colorectal carcinoma and with ageing , 1990, Nature.

[12]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .

[13]  M. Wigler,et al.  Cloning the differences between two complex genomes , 1993, Science.

[14]  B. Emanuel,et al.  Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma , 1993, Nature Genetics.

[15]  R. Weinberg,et al.  Function of a human cyclin gene as an oncogene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  B. Ponder,et al.  Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours. , 1994, Genes, chromosomes & cancer.

[17]  J. Biegel,et al.  Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. , 1994, Cancer research.

[18]  C. James,et al.  CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. , 1994, Cancer research.

[19]  V. Chapman,et al.  Direct determination of NotI cleavage sites in the genomic DNA of adult mouse kidney and human trophoblast using whole-range restriction landmark genomic scanning. , 1994, DNA research : an international journal for rapid publication of reports on genes and genomes.

[20]  P. Meltzer,et al.  Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection , 1994, Nature Genetics.

[21]  B. Dutrillaux,et al.  Predominance of normal karyotype in colorectal tumors from hereditary non‐polyposis colorectal cancer patients , 1995, Genes, chromosomes & cancer.

[22]  H. Scherthan,et al.  Advances in Brief Comparative Genomic in Situ Hybridization of Colon Carcinomas with Replication Error ' , 2006 .

[23]  G. Hannon,et al.  Deletion of the p16 and p15 genes in human bladder tumors. , 1995, Journal of the National Cancer Institute.

[24]  J. Olson,et al.  Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. , 1995, Cancer research.

[25]  B. Dutrillaux,et al.  DNA‐repeat instability is associated with colorectal cancers presenting minimal chromosome rearrangements , 1995, Genes, chromosomes & cancer.

[26]  D. Pinkel,et al.  Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. , 1995, Genes & development.

[27]  J. Bartek,et al.  Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control. , 1995, Cancer research.

[28]  Direct determination of NotI cleavage sites in the genomic DNA of adult mouse kidney and human trophoblast using whole-range restriction landmark genomic scanning , 1995 .

[29]  S. Kern,et al.  Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Ledbetter,et al.  Multicolor Spectral Karyotyping of Human Chromosomes , 1996, Science.

[31]  A. Kurt,et al.  Microsatellite alterations in plasma DNA of small cell lung cancer patients , 1996, Nature Medicine.

[32]  David Sidransky,et al.  Microsatellite alterations in serum DNA of head and neck cancer patients , 1996, Nature Medicine.

[33]  Thomas Ried,et al.  Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors , 1996, Genes, chromosomes & cancer.

[34]  Michael R. Speicher,et al.  The coloring of cytogenetics , 1996, Nature Medicine.

[35]  C. Boland,et al.  Loss of DNA mismatch repair in acquired resistance to cisplatin. , 1996, Cancer research.

[36]  J. Bartek,et al.  The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. , 1996, Cancer research.

[37]  Kazuhiro Yoshida,et al.  Telomerase activity in human breast cancer and benign breast lesions: Diagnostic applications in clinical specimens, including fine needle aspirates , 1996, International journal of cancer.

[38]  M. Greaves.  Is telomerase activity in cancer due to selection of stem cells and differentiation arrest? , 1996, Trends in genetics : TIG.

[39]  J. Inazawa,et al.  Analysis of numerical aberrations in specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer , 1996, Cancer.

[40]  O. Kallioniemi,et al.  Genetic changes in intraductal breast cancer detected by comparative genomic hybridization. , 1997, The American journal of pathology.

[41]  J Isola,et al.  Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. , 1997, Cancer research.

[42]  D. Birnbaum,et al.  Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma. , 1997, Cytogenetics and cell genetics.

[43]  D. Morris,et al.  Identification of a MMTV insertion mutation within the coding region of the Fgf-3 protooncogene. , 1997, Virology.

[44]  A. Schäffer,et al.  Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. , 1997, Cancer research.

[45]  P. Lichter.  Multicolor FISHing: what's the catch? , 1997, Trends in genetics : TIG.

[46]  S. Roka,et al.  Detection of chromosomal aneuploidy by interphase fluorescence in situ hybridization in bronchoscopically gained cells from lung cancer patients. , 1997, Chest.

[47]  H. Döhner,et al.  Matrix‐based comparative genomic hybridization: Biochips to screen for genomic imbalances , 1997, Genes, chromosomes & cancer.

[48]  D. Johnston,et al.  Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[49]  J Isola,et al.  Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. , 1997, Cancer research.

[50]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[51]  T. Anantharaman,et al.  Automated high resolution optical mapping using arrayed, fluid-fixed DNA molecules. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[52]  C. Poremba,et al.  Telomerase activity in human proliferative breast lesions. , 1998, International journal of oncology.

[53]  Bert Vogelstein,et al.  Mutations of mitotic checkpoint genes in human cancers , 1998, Nature.

[54]  W. Kuo,et al.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.

[55]  Steinbeck Rg.  Chromosome division figures reveal genomic instability in tumorigenesis of human colon mucosa. , 1998 .

[56]  James M. Roberts,et al.  The murine gene p27Kip1 is haplo-insufficient for tumour suppression , 1998, Nature.

[57]  R. Steinbeck.  Chromosome division figures reveal genomic instability in tumorigenesis of human colon mucosa. , 1998, British Journal of Cancer.

[58]  J. Rowley,et al.  The critical role of chromosome translocations in human leukemias. , 1998, Annual review of genetics.

[59]  P. O’Connell,et al.  Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. , 1998, Journal of the National Cancer Institute.

[60]  F. Marshall,et al.  Diagnosis of renal cancer by molecular urinalysis. , 1999, Journal of the National Cancer Institute.

[61]  B. Dutrillaux,et al.  TP53 status and gene amplification in human colorectal carcinomas. , 1999, Cancer genetics and cytogenetics.

[62]  Joe W. Gray,et al.  PIK3CA is implicated as an oncogene in ovarian cancer , 1999, Nature Genetics.

[63]  S. Elledge,et al.  Cyclin D- and E-Dependent Kinases and the p57KIP2 Inhibitor: Cooperative Interactions In Vivo , 1999, Molecular and Cellular Biology.

[64]  B. Scheithauer,et al.  Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype , 1999, Oncogene.

[65]  S. P. Fodor,et al.  High density synthetic oligonucleotide arrays , 1999, Nature Genetics.

[66]  J. Haber.  DNA recombination: the replication connection. , 1999, Trends in biochemical sciences.

[67]  M. Speicher,et al.  Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[68]  F. Waldman,et al.  Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. , 1999, The American journal of pathology.

[69]  D. Pinkel,et al.  Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. , 1999, The Journal of investigative dermatology.

[70]  Robert A. Weinberg,et al.  Creation of human tumour cells with defined genetic elements , 1999, Nature.

[71]  J. Rüschoff,et al.  Molecular diagnostics of cancer predisposition: hereditary non-polyposis colorectal carcinoma and mismatch repair defects. , 1999, Biochimica et biophysica acta.

[72]  W. Kuo,et al.  Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene , 2000, Nature Genetics.

[73]  S. Devries,et al.  Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. , 2000, Journal of the National Cancer Institute.

[74]  M. Merchant,et al.  A rapid protein profiling system that speeds study of cancer and other diseases. , 2000, American clinical laboratory.

[75]  P. May,et al.  Cell cycle control and cancer. , 2000, Pathologie-biologie.

[76]  A. Balmain,et al.  Allele‐specific loss or imbalance of chromosomes 9, 15, and 16 in B‐cell tumors from interspecific F1 hybrid mice carrying eμ‐c‐myc or N‐myc transgenes , 2000, International journal of cancer.

[77]  Y. Chen,et al.  Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. , 2000, Journal of the National Cancer Institute.

[78]  R. Jenkins,et al.  The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. , 2000, The Journal of molecular diagnostics : JMD.

[79]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[80]  S. Knuutila,et al.  Online access to CGH data of DNA sequence copy number changes. , 2000, The American journal of pathology.

[81]  J. Kononen,et al.  Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. , 2000, Cancer research.

[82]  J W Gray,et al.  An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. , 2000, Cancer research.

[83]  G. Levi,et al.  Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4 , 2000, Oncogene.

[84]  R. DePinho,et al.  A critical role for telomeres in suppressing and facilitating carcinogenesis. , 2000, Current opinion in genetics & development.

[85]  Emanuel Petricoin,et al.  Molecular profiling of human cancer , 2000, Nature Reviews Genetics.

[86]  S. Elledge,et al.  Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. , 2000, Genes & development.

[87]  T. Godfrey,et al.  Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. , 2000, Cancer research.

[88]  J. Sudbø,et al.  Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.

[89]  W. Gerald,et al.  MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells , 2001, Nature.

[90]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[91]  R. DePinho,et al.  Telomere dysfunction and evolution of intestinal carcinoma in mice and humans , 2001, Nature Genetics.

[92]  W. Hahn,et al.  Derivation of human tumor cells in vitro without widespread genomic instability. , 2001, Cancer research.

[93]  C. Fauth,et al.  Classifying by colors: FISH-based genome analysis , 2001, Cytogenetic and Genome Research.

[94]  D. Schild,et al.  Homologous recombinational repair of DNA ensures mammalian chromosome stability. , 2001, Mutation research.

[95]  K. Khanna,et al.  ATM, a central controller of cellular responses to DNA damage , 2001, Cell Death and Differentiation.

[96]  E. Petricoin,et al.  Cancer proteomics: from biomarker discovery to signal pathway profiling. , 2001, Cancer journal.

[97]  Thomas D. Schmittgen,et al.  Real-Time Quantitative PCR , 2002 .

[98]  P. Jallepalli,et al.  Chromosome segregation and cancer: cutting through the mystery , 2001, Nature Reviews Cancer.

[99]  D. Botstein,et al.  Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF , 2001, Nature.

[100]  Jeremy M. Stark,et al.  Double-strand breaks and tumorigenesis. , 2001, Trends in cell biology.

[101]  P. N. Rao,et al.  Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification , 2001, Science.

[102]  E. Petricoin,et al.  Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front , 2001, Oncogene.

[103]  Richard D. Wood,et al.  Human DNA Repair Genes , 2001, Science.

[104]  L. Liotta,et al.  Proteomic profiling of the cancer microenvironment by antibody arrays , 2001, Proteomics.

[105]  Petricoin Ef rd,et al.  Cancer proteomics: from biomarker discovery to signal pathway profiling. , 2001, Cancer journal.

[106]  W. Hanna.  Testing for HER2 Status , 2001, Oncology.

[107]  A. Berns,et al.  Haplo-insufficiency? Let me count the ways. , 2001, Genes & development.

[108]  S. Devries,et al.  Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[109]  P. Edwards,et al.  Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[110]  L. Aaltonen,et al.  Comparison of Serous and Mucinous Ovarian Carcinomas: Distinct Pattern of Allelic Loss at Distal 8p and Expression of Transcription Factor GATA-4 , 2001, Laboratory Investigation.

[111]  Ajay N. Jain,et al.  Assembly of microarrays for genome-wide measurement of DNA copy number , 2001, Nature Genetics.

[112]  Joe W. Gray,et al.  Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas , 2001, Nature Genetics.

[113]  J. Hoeijmakers,et al.  Chromosomal stability and the DNA double-stranded break connection , 2001, Nature Reviews Genetics.

[114]  Debabrata Banerjee,et al.  Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. , 2002, Biochimica et biophysica acta.

[115]  K. Haigis,et al.  Intestinal adenomas can develop with a stable karyotype and stable microsatellites , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[116]  S. Artandi.  Telomere shortening and cell fates in mouse models of neoplasia. , 2002, Trends in molecular medicine.

[117]  Martin Lipkin,et al.  Migrating colonic crypt epithelial cells: primary targets for transformation. , 2002, Carcinogenesis.

[118]  T. Hoang,et al.  Gradient of E2A Activity in B-Cell Development , 2002, Molecular and Cellular Biology.

[119]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[120]  Erich A. Nigg,et al.  Centrosome aberrations: cause or consequence of cancer progression? , 2002, Nature Reviews Cancer.

[121]  D. Schild,et al.  Recombinational DNA repair and human disease. , 2002, Mutation research.

[122]  Ajay N. Jain,et al.  Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. , 2002, Cancer research.

[123]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[124]  W. Lingle,et al.  Centrosome amplification and the development of cancer , 2002, Oncogene.

[125]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[126]  M. Ringnér,et al.  Impact of DNA amplification on gene expression patterns in breast cancer. , 2002, Cancer research.

[127]  M. Morrow,et al.  Chemoprevention of breast cancer: a model for change. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[128]  G. Evan,et al.  Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic Progression , 2002, Cell.

[129]  O. Olopade,et al.  Cyclin D1 Amplification and p16(MTS1/CDK4I) Deletion Correlate With Poor Prognosis in Head and Neck Tumors , 2002, The Laryngoscope.

[130]  Christian A. Rees,et al.  Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[131]  Marcel J T Reinders,et al.  Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors. , 2002, Cancer research.

[132]  G. Boivin,et al.  Enhanced Tumor Formation in Mice Heterozygous for Blm Mutation , 2002, Science.

[133]  T. Lange.  Protection of mammalian telomeres , 2002, Oncogene.

[134]  M. Robinson,et al.  Telomere dysfunction: multiple paths to the same end , 2002, Oncogene.

[135]  C. Ball,et al.  Identification of genes periodically expressed in the human cell cycle and their expression in tumors. , 2002, Molecular biology of the cell.

[136]  C. Bloomfield,et al.  Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. , 2002, International journal of oncology.

[137]  M. Koshiji,et al.  Microsatellite analysis of fecal DNA for colorectal cancer detection * , 2002, Journal of surgical oncology.

[138]  J. Baselga.  Why the epidermal growth factor receptor? The rationale for cancer therapy. , 2002, The oncologist.

[139]  J. Shay,et al.  Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. , 2002, Differentiation; research in biological diversity.

[140]  D. Medina.  Biological and molecular characteristics of the premalignant mouse mammary gland. , 2002, Biochimica et biophysica acta.

[141]  R. Dahse,et al.  Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[142]  Kyoung-Mee Kim,et al.  Methylation reveals a niche: stem cell succession in human colon crypts , 2002, Oncogene.

[143]  Bert Vogelstein,et al.  Allelic Variation in Human Gene Expression , 2002, Science.

[144]  Cestmir Vlcek,et al.  Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers , 2002, Nature Genetics.

[145]  J. Baselga,et al.  HER-Targeted Tyrosine-Kinase Inhibitors , 2002, Oncology.

[146]  J. Mendelsohn.  Targeting the epidermal growth factor receptor for cancer therapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[147]  M. Winey,et al.  Centrosomes and tumour suppressors. , 2002, Current opinion in cell biology.

[148]  M. Gerstein,et al.  GATA-1 binding sites mapped in the β-globin locus by using mammalian chIp-chip analysis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[149]  A. Balmain.  Cancer: New-age tumour suppressors , 2002, Nature.

[150]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[151]  R. Reddel,et al.  Alternative lengthening of telomeres in mammalian cells , 2002, Oncogene.

[152]  E. Gabrielson,et al.  Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer. , 2002, The American journal of pathology.

[153]  C. Deng,et al.  Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer , 2002, Oncogene.

[154]  O. Sieber,et al.  Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[155]  A. Sparks,et al.  Using the transcriptome to annotate the genome , 2002, Nature Biotechnology.

[156]  Colin C. Collins,et al.  Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors , 2002, Nature Genetics.

[157]  Kim Nasmyth,et al.  Segregating Sister Genomes: The Molecular Biology of Chromosome Separation , 2002, Science.

[158]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[159]  R. DePinho,et al.  Connecting chromosomes, crisis, and cancer. , 2002, Science.

[160]  Lyndsay N Harris,et al.  Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[161]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[162]  P. Cutler.  Protein arrays: The current state‐of‐the‐art , 2003, Proteomics.

[163]  Jane Fridlyand,et al.  Shaping of tumor and drug-resistant genomes by instability and selection , 2003, Oncogene.

[164]  H. Ireland,et al.  High levels of telomere dysfunction bestow a selective disadvantage during the progression of human oral squamous cell carcinoma. , 2003, Cancer research.

[165]  K. Haigis,et al.  A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity , 2003, Nature Genetics.

[166]  Daniela S Krause,et al.  Tyrosine kinases as targets for cancer therapy. , 2005, The New England journal of medicine.